摘要 |
The invention relates to novel decahydroquinolinol derivatives represented by the general formula: <IMAGE> and pharmaceutically acceptable acid addition salts thereof, in which X represents oxygen or sulphur, R represents an alkyl radical having from 1 to 3 carbon atoms, R1 represents fluorine, chlorine, bromine or methoxy, R2 represents hydrogen or methoxy or R1 and R2, when they are taken together, represent a 2,3-methylenedioxy or 3,4-methylenedioxy radical. The compounds of the invention are inhibitors of calcium translocation at the level of the cell membrane and are useful more particularly in the treatment of pathological syndromes of the cardiovascular system such as, for instance, angina pectoris. |